Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
Interest Expense Over TimeStable
Percentile Rank64
3Y CAGR+62.7%
5Y CAGR+2.1%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+62.7%/yr
vs -33.0%/yr prior
5Y CAGR
+2.1%/yr
Recent acceleration
Acceleration
+95.7pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $32.75M | -0.9% |
| 2024 | $33.03M | +52.7% |
| 2023 | $21.63M | +184.7% |
| 2022 | $7.60M | -75.6% |
| 2021 | $31.15M | +5.7% |
| 2020 | $29.48M | -19.5% |
| 2019 | $36.60M | -3.0% |
| 2018 | $37.72M | +3.7% |
| 2017 | $36.37M | -7.1% |
| 2016 | $39.15M | - |